Actively Recruiting
Minimally Invasive Surgery For Patients With Spontaneous Deep Intracerebral Hemorrhage
Led by Huynh Quoc Huy · Updated on 2025-11-19
300
Participants Needed
1
Research Sites
155 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational cohort study evaluates the safety and effectiveness of minimally invasive surgery (MIS) compared with standard medical management in adults with spontaneous deep intracerebral hemorrhage. Consecutive patients admitted to People's Hospital 115 and Tam Anh General Hospital will be enrolled within 72 hours of onset. Clinical and imaging data will be collected prospectively, and outcomes including survival and functional status will be assessed through 180 days.
CONDITIONS
Official Title
Minimally Invasive Surgery For Patients With Spontaneous Deep Intracerebral Hemorrhage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 80 years
- Spontaneous basal ganglia intracerebral hemorrhage confirmed by non-contrast CT scan
- Hematoma volume between 30 and 80 mL measured by ABC/2 method
- Time from symptom onset or last known well is 72 hours or less
- Glasgow Coma Scale score between 5 and 14 at admission
- Pre-stroke modified Rankin Scale score of 0 to 1
You will not qualify if you...
- Intracerebral hemorrhage caused by trauma, tumor, vascular malformation, aneurysm, or hemorrhagic transformation of ischemic stroke
- Hemorrhage located in brainstem or cerebellum (infratentorial)
- Primary thalamic hemorrhage
- Extensive intraventricular hemorrhage affecting more than 50% of one lateral ventricle
- National Institutes of Health Stroke Scale score less than 5 at admission
- Bilateral fixed dilated pupils without light reflex
- Decerebrate posture
- Platelet count below 75,000/µL
- International Normalized Ratio above 1.4 after correction
- Ongoing anticoagulation that cannot be quickly reversed
- Need for long-term anticoagulation within 5 days of symptom onset
- End-stage kidney disease
- End-stage liver disease
- Presence of mechanical heart valve
- Any condition with life expectancy less than 6 months
- Patient or legal representative unwilling or unable to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
People's Hospital 115
Ho Chi Minh City, Ho Chi Minh, Vietnam, 700000
Actively Recruiting
Research Team
H
Huy Q Huynh, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here